Full-Length Complementary DNA of Hepatitis C Virus Genome From an Infectious Blood Sample

Fig. 1. Clinical characteristics of the recipient. The profiles of ALT values (IU/L) and anti-HCV antibody (C-100 and p-22) titers in the recipient from March 1988 to September 1991 are shown. Open squares indicate the periods of blood transfusion (BT) and IFN treatment (IFN-). HCV RNA titer was measured by use of competitive PCR.²⁴ HCV RNA, whose titer was less than 10³, was detected by using RT-nested PCR of the 5′ noncoding region.²⁵ Arrows denote the times when plasma specimens were obtained for analysis of HCV RNA.

 

Return To Article

Table of Contents